女性科技市場機會、成長動力、產業趨勢分析及 2025-2034 年預測

2024 年全球女性科技市場價值為 602 億美元，預計 2025 年至 2034 年期間的複合年成長率為 16%。 Femtech 是女性科技的縮寫，專注於開發創新產品、服務和平台，以滿足女性獨特的醫療保健需求。這些包括生育、懷孕、生殖健康、更年期、性健康和一般健康的解決方案。尤其是在已開發國家，人們越來越依賴數位科技來管理女性健康，這極大地推動了市場的成長。

女性癌症、糖尿病、高血壓等慢性病和精神健康問題日益增多，推動了對個人化、技術驅動型醫療保健的需求。 Femtech 提供客製化工具，幫助女性應對複雜的健康挑戰，進一步促進市場發展。人們對以女性為中心的健康問題的認知不斷提高，以及穿戴式和行動健康設備的發展，推動了對可獲得且有針對性的解決方案的需求。先進技術融入女性日常醫療保健，鼓勵更多女性採用數位平台，創造了強勁的市場動能。

從類型來看，2024 年女性科技市場規模估計為 602 億美元，其中產品部分貢獻 115 億美元，預計 2025 年至 2034 年期間的成長率為 13.8%。個人化醫療解決方案需求的不斷成長以及穿戴式裝置和行動醫療技術的快速發展，正在提高產品的採用率。人們對妊娠併發症的認知不斷提高，以及對監測和管理女性健康的創新工具的需求進一步支持了市場前景。在應用方面，女性科技分為懷孕和護理、生殖健康、骨盆和子宮保健、一般醫療保健和健康等。

生殖健康領域在 2024 年佔據市場主導地位，收入達 264 億美元，佔有 43.9% 的佔有率。人們對生育、懷孕、月經和更年期相關健康問題的認知不斷提高，加上討論這些問題的開放程度不斷提高，對專業生殖健康解決方案的需求也不斷增加。先進的穿戴式裝置、行動應用程式和遠距醫療的結合改變了生殖健康管理，推動了市場的發展。

根據最終用途，市場分為直接面對消費者、醫院、生育診所、外科中心、診斷中心和其他。到 2024 年，直接面對消費者的市場規模將達到 195 億美元，這得益於人們對可在家中使用的個人化醫療工具的偏好日益成長。越來越多的女性選擇能夠滿足敏感健康需求同時又能確保隱私和便利的產品。女性科技公司也利用用戶資料來創建更有效、更客製化的解決方案，從而提高客戶滿意度和市場滲透率。

從地區來看，2024 年北美創造了 195 億美元的收入，其中美國佔比 89.2%，這主要是由於人們越來越關注女性健康，以及對可獲得且負擔得起的解決方案的需求不斷增加。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 已開發國家利用數位科技管理婦女健康
    • 改善偏遠地區婦女獲得照護的機會
    • 發展中國家對女性健康和保健的認知不斷提高
    • 女性人口慢性病及傳染病負擔加重
    • 女性科技業投資不斷成長
  • 產業陷阱與挑戰
    • 缺乏對女性科技產品與應用的認知
• 成長潛力分析
• 監管格局
• 技術格局
• 未來市場趨勢
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第5章：市場估計與預測：按類型，2021 年至 2034 年

• 主要趨勢
• 產品
• 軟體
• 服務

第6章：市場估計與預測：按應用，2021 年至 2034 年

• 生殖健康
  • 月經週期和生育能力
  • 停經
• 懷孕和護理
• 骨盆腔和子宮保健
• 一般醫療保健和健康
• 其他應用

第7章：市場估計與預測：依最終用途，2021 年至 2034 年

• 主要趨勢
• 直接面對消費者
• 醫院
• 生育診所
• 外科中心
• 診斷中心
• 其他最終用戶

第8章：市場估計與預測：按地區，2021 年至 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 俄羅斯
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
• 拉丁美洲
  • 巴西
  • 墨西哥
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯

第9章：公司簡介

• BioWink GmbH
• Athena Feminine Technologies
• Conceivable, Inc
• HeraMED
• Elvie
• iSono Health
• Nuvo Cares
• Minerva Surgical
• Prelude
• Sustain Natural
• Sera Prognostics
• Univfy
• Totohealth

The Global Femtech Market was valued at USD 60.2 billion in 2024 and is projected to expand at a CAGR of 16% between 2025 and 2034. Femtech, short for female technology, focuses on developing innovative products, services, and platforms that address women's unique healthcare needs. These include solutions for fertility, pregnancy, reproductive health, menopause, sexual wellness, and general well-being. Growing reliance on digital technologies to manage women's health, especially in developed nations, has significantly propelled market growth.

Increasing chronic conditions such as cancer, diabetes, hypertension, and mental health issues among women are fueling the demand for personalized, tech-driven healthcare. Femtech offers tailored tools that assist women in managing complex health challenges, further boosting the market. The ongoing rise in awareness around women-centric health issues and the development of wearable and mobile health devices are driving the need for accessible and targeted solutions. The integration of advanced technology into everyday healthcare for women has encouraged more women to adopt digital platforms, creating strong market momentum.

In terms of type, the femtech market was estimated at USD 60.2 billion in 2024, with the product segment contributing USD 11.5 billion and expected to register a 13.8% growth rate from 2025 to 2034. Increasing demand for personalized healthcare solutions and rapid advancements in wearable devices and mobile health technologies are enhancing product adoption. Rising awareness about pregnancy complications and the need for innovative tools for monitoring and managing women's health further support the market outlook. On the application front, femtech is divided into pregnancy and nursing care, reproductive health, pelvic and uterine healthcare, general healthcare and wellness, and others.

The reproductive health segment led the market with USD 26.4 billion in revenue in 2024, capturing a 43.9% share. Growing recognition of fertility, pregnancy, menstruation, and menopause-related health concerns, coupled with rising openness in discussing these issues, has increased demand for specialized reproductive health solutions. The incorporation of advanced wearable devices, mobile apps, and telemedicine has transformed reproductive health management, pushing the market forward.

Based on end use, the market is segmented into direct-to-consumer, hospitals, fertility clinics, surgical centers, diagnostic centers, and others. The direct-to-consumer segment accounted for USD 19.5 billion in 2024, driven by the rising preference for personalized healthcare tools accessible from home. Women are increasingly opting for products that address sensitive health needs while ensuring privacy and convenience. Femtech companies are also leveraging user data to create more effective and tailored solutions, boosting customer satisfaction and market penetration.

Regionally, North America generated USD 19.5 billion in revenue in 2024, with the U.S. accounting for 89.2% of this share, largely due to a growing focus on women's health and increasing demand for accessible and affordable solutions.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Usage of digital technology to manage women health in developed countries
    • 3.2.1.2 Improving access to women care in remote areas
    • 3.2.1.3 Growing awareness regarding women health and wellness in developing countries
    • 3.2.1.4 Increasing burden of chronic and infectious diseases among the female population
    • 3.2.1.5 Growing investments in femtech industry
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of awareness about femtech products and applications
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Products
• 5.3 Software
• 5.4 Services

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 6.1 Reproductive health
  • 6.1.1 Menstrual cycle and fertility
  • 6.1.2 Menopause
• 6.2 Pregnancy and nursing care
• 6.3 Pelvic and uterine healthcare
• 6.4 General healthcare and wellness
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Direct-to-consumer
• 7.3 Hospitals
• 7.4 Fertility clinics
• 7.5 Surgical centers
• 7.6 Diagnostic centers
• 7.7 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Russia
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia

Chapter 9 Company Profiles

• 9.1 BioWink GmbH
• 9.2 Athena Feminine Technologies
• 9.3 Conceivable, Inc
• 9.4 HeraMED
• 9.5 Elvie
• 9.6 iSono Health
• 9.7 Nuvo Cares
• 9.8 Minerva Surgical
• 9.9 Prelude
• 9.10 Sustain Natural
• 9.11 Sera Prognostics
• 9.12 Univfy
• 9.13 Totohealth